Vital Art and Science, developers of myVisionTrack, a vision test service for patients with age-related macular degeneration or diabetic eye disease, has received a second FDA clearance for their platform, which includes an app and a provider dashboard. They will also soon launch a major clinical trial in partnership with the Scripps Translational Science Institute and Roche, according to the...
Texas-based iPhone vision test startup Vital Art and Science (maker of MyVisionTrack) has raised $550,000 in first round funding from the North Texas Angel Network (NTAN).
The company's flagship product, myVisionTrack, is an iPhone 4S-based shape discrimination hyperacuity test for patients with serious degenerative eye conditions such as diabetic retinopathy (DR) and age-related macular...
One of the findings of a recent California Health Care Foundation whitepaper about health-specific accelerators was the importance of involving healthcare experts such as doctors in the organization.
Dr. Hubert Zajicek took that to heart in starting his new health tech accelerator, Health Wildcatters, in Dallas, Texas. Zajicek is a physician who specialized in nephrology, or kidney research....
The FDA has granted Class II prescription-only 510(K) clearance for an iPhone-enabled vision test. The software, called myVisionTrack, was developed by Vital Art and Science. The FDA clearance applies to the software when run on an iPhone 4S.
Vital Art and Science has developed the test for patients with serious degenerative eye conditions such as diabetic retinopathy (DR) and age-related macular...
